Cancer, a devastating disease affecting millions worldwide, is characterized by uncontrolled cell growth and genetic abnormalities. Until recent years, cancer treatment strategies were largely based on a one-size-fits-all approach. However, with advances in genomic cancer testing, we are witnessing a revolutionary shift towards personalized and targeted therapies. Genomic cancer testing, also known as molecular profiling or genetic testing, ... Read more
The Global Genomic Cancer Testing Market Is Estimated To Be Valued At US$16.15 Billion In 2023 And Is Expected To Exhibit A CAGR Of 16.1% Over The Forecast Period (2023-2030), As Highlighted In A New Report Published By Coherent Market Insights.
A) Market Overview:
Genomic Cancer Testing Is A Type Of Diagnostic Testing That Involves Analyzing A Person's Genetic Material To Identify Changes Or Mutations That May Increase The Risk Of Developing Cancer. This Testing ... Read more
The Genomic Cancer Testing Market is estimated to be valued at US$16.15 billion in 2023 and is expected to exhibit a CAGR of 16.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Genomic cancer testing involves analyzing the DNA or RNA of a cancer cell to identify genetic abnormalities and provide insights into the disease ... Read more
Genomic cancer testing involves analyzing the complete set of genes or genome of cancerous cells or a tumor to check for any mutations or other changes that can help determine a patient's risk for cancer, detect cancer in early stages, prognosis, targeted therapies, and monitor recurrence. Such testing offers oncologists and physicians deep clinical insights to develop more personalized and targeted treatment plans for cancer patients.
The global Genomic Cancer Testing Market ... Read more
Genomic cancer testing involves analyzing the complete set of genes or genome of cancerous cells or a tumor to check for any mutations or other changes that can help determine a patient's risk for cancer, detect cancer in early stages, prognosis, targeted therapies, and monitor recurrence. Such testing offers oncologists and physicians deep clinical insights to develop more personalized and targeted treatment plans for cancer patients.
The global Genomic Cancer Testing Market ... Read more
